| T Lymphoblastic Lymphoma studied in …STUDIED_INderived26 of 26show fewer |
|---|
| → studied in | NCT04315324Phase 1/Phase 2 · active not recruiting Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL) · condition mapped CURATED_BROADER · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03504644Phase 1/Phase 2 · active not recruiting Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072585Phase 2/Phase 3 · not yet recruiting Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00501826Phase 2 · recruiting Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07678307Phase 1/Phase 2 · not yet recruiting A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408005Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07523555Phase 1/Phase 2 · recruiting Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476027early Phase 1 · not yet recruiting Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05170828Phase 1 · withdrawn Cryopreserved MMUD BM With PTCy for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06741813NA · not yet recruiting Allo-HSCT vs ASCT in Adult T-LBL · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06633341early Phase 1 · recruiting Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06434467Phase 3 · unknown The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06210750Phase 2 · withdrawn Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06376721Phase 1/Phase 2 · recruiting Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04582487NA · unknown Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04828174Phase 1 · suspended Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06136364Phase 1 · recruiting CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02763384Phase 2 · terminated BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | Adult T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05576532Phase 2 · unknown Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01028716Phase 2 · terminated Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04860817early Phase 1 · withdrawn A Study of Anti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBL · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04620655NA · unknown RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04004637Phase 1 · unknown CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01363817Phase 1 · completed Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma · condition mapped ALIAS · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02538926Phase 2 · withdrawn Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · condition mapped CURATED_BROADER · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03558412Phase 4 · unknown A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma · condition mapped ONTOLOGY_EXACT · 26 trials mapped (11 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |